P1037: CONSISTENCY OF PACRITINIB FOR SPLEEN AND SYMPTOM REDUCTION IN PATIENTS WITH MYELOFIBROSIS REGARDLESS OF CYTOPENIAS

por Gagelmann, Nico, Gupta, Vikas, Mclornan, Donal P, Bose, Prithviraj, Vachhani, Pankit, Kathrin Al-Ali, Haifa, Ali, Haris, Treskes, Philipp, Buckley, Sarah, Roman-Torres, Karisse, Scott, Bart
Publicado 2023

P1030: SPLEEN VOLUME REDUCTION PREDICTS SURVIVAL IN MYELOFIBROSIS PATIENTS ON PACRITINIB BUT NOT BEST AVAILABLE THERAPY: PERSIST-2 LANDMARK OVERALL SURVIVAL ANALYSIS

por Bewersdorf, Jan, Ajufo, Helen, Harrison, Claire, Palandri, Francesca, Mascarenhas, John, Palmer, Jeanne, Gerds, Aaron T., Kiladjian, Jean-Jacques, Derkach, Andrii, Roman-Torres, Karisse, Buckley, Sarah, Rampal, Raajit K
Publicado 2023

Retrospective analysis of pacritinib in patients with myelofibrosis and severe thrombocytopenia

por Verstovsek, Srdan, Mesa, Ruben, Talpaz, Moshe, Kiladjian, Jean-Jacques, Harrison, Claire N., Oh, Stephen T., Vannucchi, Alessandro M., Rampal, Raajit, Scott, Bart L., Buckley, Sarah A., Craig, Adam R., Roman-Torres, Karisse, Mascarenhas, John O.
Publicado 2021

Risk‐adjusted safety analysis of the oral JAK2/IRAK1 inhibitor pacritinib in patients with myelofibrosis

por Pemmaraju, Naveen, Harrison, Claire, Gupta, Vikas, Verstovsek, Srdan, Scott, Bart, Oh, Stephen T., Palandri, Francesca, Al‐Ali, Haifa Kathrin, Sobas, Marta, McMullin, Mary Frances, Mesa, Ruben, Buckley, Sarah, Roman‐Torres, Karisse, Vannucchi, Alessandro, Yacoub, Abdulraheem
Publicado 2022

Efficacy and Safety of Pacritinib vs Placebo for Patients With Severe COVID-19: A Phase 2 Randomized Clinical Trial

por Cafardi, John, Miller, Carole, Terebelo, Howard, Tewell, Chad, Benzaquen, Sadia, Park, David, Egan, Pamela, Lebovic, Daniel, Pettit, Kristen, Whitman, Eric, Tremblay, Douglas, Feld, Jonathan, Buckley, Sarah, Roman-Torres, Karisse, Smith, Jennifer, Craig, Adam, Mascarenhas, John
Publicado 2022

Pacritinib is a potent ACVR1 inhibitor with significant anemia benefit in patients with myelofibrosis

por Oh, Stephen T., Mesa, Ruben A., Harrison, Claire N., Bose, Prithviraj, Gerds, Aaron T., Gupta, Vikas, Scott, Bart L., Kiladjian, Jean-Jacques, Lucchesi, Alessandro, Kong, Tim, Buckley, Sarah A., Tyavanagimatt, Shanthakumar, Harder, Bryan G., Roman-Torres, Karisse, Smith, Jennifer, Craig, Adam R., Mascarenhas, John, Verstovsek, Srdan
Publicado 2023